EUVIMEDEUVIMED entdecken
Crossref

Spironolactone in the Management of Congestive Heart Failure

S R Kayser

Progress in Cardiovascular Nursing · 2000

DOI: 10.1111/j.0889-7204.2000.080403.x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Progress in Cardiovascular Nursing, 2000. Verfasst von S R Kayser. Beteiligte Einrichtung: Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, USA. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiureticsHeart FailureHumansMineralocorticoid Receptor AntagonistsPractice Guidelines as TopicRandomized Controlled Trials as TopicSpironolactoneTreatment Outcome

Substanzen

DiureticsMineralocorticoid Receptor AntagonistsSpironolactone

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, USA.

Zitieren

APA

Kayser, S. R. (2000). Spironolactone in the Management of Congestive Heart Failure. Progress in Cardiovascular Nursing. https://doi.org/10.1111/j.0889-7204.2000.080403.x

Vancouver

Kayser SR. Spironolactone in the Management of Congestive Heart Failure. Progress in Cardiovascular Nursing. 2000. doi:10.1111/j.0889-7204.2000.080403.x

BibTeX
@article{Kayser2000,
  author = {Kayser, S R},
  title = {Spironolactone in the Management of Congestive Heart Failure},
  journal = {Progress in Cardiovascular Nursing},
  year = {2000},
  doi = {10.1111/j.0889-7204.2000.080403.x}
}
Kostenlos starten →